|
|
 Previous Article | Table of Contents | Next Article 
Synergistic Action of Flt3 and gp130 Signalings in Human Hematopoiesis
Yasuhiro Ebihara,
Kohichiro Tsuji,
Stewart D. Lyman,
Xingwei Sui,
Makoto Yoshida,
Kenji Muraoka,
Kaoru Yamada,
Ryuhei Tanaka, and
Tatsutoshi Nakahata
From the Department of Clinical Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; and Immunex Corporation, Seattle, WA.
We recently showed that c-kit signal synergizes with glycoprotein (gp)130 signal mediated by a complex of interleukin (IL)-6 and soluble IL-6 receptor (IL-6/sIL-6R) to stimulate the expansion of human primitive hematopoietic progenitor cells and erythropoietin-independent erythropoiesis. In the present study, we examined the effect of a ligand for Flt3 (FL), whose receptor tyrosine kinase is closely related to c-kit, in combination with IL-6/sIL-6R on human hematopoiesis in vitro. In serum-containing methylcellulose clonal culture of cord blood CD34+ cells, whereas FL alone stimulated only granulocyte-macrophage (GM) colony formation, erythroid bursts and mixed colonies in addition to GM colonies were induced by FL with IL-6/sIL-6R, but not IL-6/sIL-6R alone. In suspension culture, CD34+ cells generated a small number of myeloid cells in the presence of FL or IL-6/sIL-6R alone. However, the addition of IL-6/sIL-6R to the culture with FL induced the generation of a significant number of erythroid cells and megakaryocytes in addition to myeloid cells. The combination of FL and IL-6/sIL-6R also induced a remarkable expansion of GM colony- and erythroid burst-forming cells and multipotential progenitors, although FL or IL-6/sIL-6R alone induced the generation of only a small number of progenitors for GM colonies. The synergistic effects of FL and IL-6/sIL-6R were confirmed in serum-free clonal and suspension cultures. In addition, the addition of anti-human gp130 monoclonal antibodies abrogated the synergistic action. These results indicate that Flt3 signal, as well as c-kit signal, synergizes with gp130 signal to stimulate human myelopoiesis, erythropoiesis and megakaryopoiesis, and the expansion of primitive multipotential hematopoietic progenitor cells.
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4363-4368
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. A. Cohen, G. K. Koski, B. J. Czerniecki, K. D. Bunting, X.-Y. Fu, Z. Wang, W.-J. Zhang, C. S. Carter, M. Awad, C. A. Distel, et al.
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells
Blood,
September 1, 2008;
112(5):
1832 - 1843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ohtsuka, A. Manabe, H. Kawasaki, D. Hasegawa, Y. Zaike, S. Watanabe, T. Tanizawa, T. Nakahata, and K. Tsuji
RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro
Blood,
November 1, 2005;
106(9):
3134 - 3141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kindler, F. Breitenbuecher, S. Kasper, E. Estey, F. Giles, E. Feldman, G. Ehninger, G. Schiller, V. Klimek, S. D. Nimer, et al.
Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML)
Blood,
January 1, 2005;
105(1):
335 - 340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G. Gilliland and J. D. Griffin
The roles of FLT3 in hematopoiesis and leukemia
Blood,
August 13, 2002;
100(5):
1532 - 1542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-D. Wang, Z.-J. Gu, J.-A. Huang, Y.-B. Zhu, Z.-H. Zhou, W. Xie, Y. Xu, Y.-H. Qiu, and X.-G. Zhang
gp130-linked signal transduction promotes the differentiation and maturation of dendritic cells
Int. Immunol.,
June 1, 2002;
14(6):
599 - 603.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Ma, M. Wada, H. Yoshino, Y. Ebihara, T. Ishii, A. Manabe, R. Tanaka, T. Maekawa, M. Ito, H. Mugishima, et al.
Development of human lymphohematopoietic stem and progenitor cells defined by expression of CD34 and CD81
Blood,
June 15, 2001;
97(12):
3755 - 3762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Audet, C. L. Miller, S. Rose-John, J. M. Piret, and C. J. Eaves
Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells
PNAS,
February 13, 2001;
98(4):
1757 - 1762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Kollet, R. Aviram, J. Chebath, H. ben-Hur, A. Nagler, L. Shultz, M. Revel, and T. Lapidot
The Soluble Interleukin-6 (IL-6) Receptor/IL-6 Fusion Protein Enhances In Vitro Maintenance and Proliferation of Human CD34+CD38-/low Cells Capable of Repopulating Severe Combined Immunodeficiency Mice
Blood,
August 1, 1999;
94(3):
923 - 931.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F.-C. Yang, S. Watanabe, K. Tsuji, M.-j. Xu, A. Kaneko, Y. Ebihara, and T. Nakahata
Human Granulocyte Colony-Stimulating Factor (G-CSF) Stimulates the In Vitro and In Vivo Development But Not Commitment of Primitive Multipotential Progenitors From Transgenic Mice Expressing the Human G-CSF Receptor
Blood,
December 15, 1998;
92(12):
4632 - 4640.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
